TS Financial Group (TSFG)’s Amneal Pharmaceuticals AMRX Stock Holding History

TS Financial Group (TSFG)’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,350	Closed	-$6K	–	871
2023 Q3	$6K	Hold	1,350	–	–	﹤0.01%	612
2023 Q2	$4K	Hold	1,350	–	–	﹤0.01%	677
2023 Q1	$2K	Hold	1,350	–	–	﹤0.01%	789
2022 Q4	$3K	Hold	1,350	–	–	﹤0.01%	723
2022 Q3	$3K	Hold	1,350	–	–	﹤0.01%	693
2022 Q2	$4K	Buy	+1,350	New	+$4.89K	﹤0.01%	662

Other funds holding AMRX

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TS Financial Group (TSFG)'s AMRX Position: Q4 2023 in Review

TS Financial Group (TSFG) sold out of Amneal Pharmaceuticals (AMRX) in Q4 2023, closing a stake of 1,350 shares — an estimated $6K sold.

TS Financial Group (TSFG) first reported a position in AMRX in Q2 2022 and held it in 6 quarters. The position peaked at $6K in Q3 2023. 153 funds tracked by Wall St. Rank hold AMRX as of Q4 2023.

TS Financial Group (TSFG) reported no remaining Amneal Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
TS Financial Group (TSFG) sold 1,350 Amneal Pharmaceuticals shares in Q4 2023, an estimated $6K.
TS Financial Group (TSFG) first reported a position in Amneal Pharmaceuticals in Q2 2022 and held it in 6 quarters.
TS Financial Group (TSFG)'s Amneal Pharmaceuticals position peaked at $6K in Q3 2023.
153 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2023.

Based on TS Financial Group (TSFG)'s 13F filing for Q4 2023, filed 24 Jan 2024.